对柏柏林纳米颗粒的评估作为调节乙胆化酶活性的策略
Fernanda Vitória Leimann1, Luma Borges de Souza2, Byanca Pereira Moreira de Oliveira3
1Post-Graduation Program of Food Technology (PPGTA), Federal University of Technology - Paraná - UTFPR, Brazil; Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, Bragança, Portugal.
柏柏林固体分散 (SD) 显示出作为神经退行性疾病的乙胆酶抑制剂的潜力. 这些改进的柏柏林配方证明了安全性和有效性,为新的治疗纳米结构铺平了道路.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 生物化学 生物化学
- 纳米技术纳米技术
背景情况:
- 胆酶抑制剂对于治疗退行性疾病至关重要.
- 柏柏林是一种植物化物,抑制了乙胆酶,但具有较差的溶解性和生物可用性.
- 固体分散技术提供了一种方法来增强像柏柏林这样的疏水化合物对水的亲和力.
研究的目的:
- 为了研究柏柏林载体固体分散剂 (SD) 作为乙胆酶 (AChE) 抑制剂的疗效.
- 通过体内测试来评估柏柏林SD的安全性.
- 探索柏柏林SD在神经退行性疾病治疗纳米结构开发中的潜力.
主要方法:
- 分子对接模拟来分析贝贝林与ACHE的相互作用.
- 在体外酶分析以确定ACHE抑制动力学.
- 对瘤细胞的细胞毒性测定.
- 在体内基因毒性和细胞毒性测试使用Allium cepa.
主要成果:
- 柏柏林证明了对AChE的抑制作用.
- 柏柏林固体分散物在水性介质中对瘤细胞表现出增强的细胞毒性作用.
- 在体内测试证实了柏柏林SD的安全性,没有显示细胞毒性或基因毒性.
结论:
- 柏柏林固体分散是一种有前途的方法,可以克服柏柏林的不良溶解性和生物可用性.
- 开发的柏柏林SD配方是安全有效的ACHE抑制剂.
- 柏柏林SD作为治疗神经退行性疾病的安全纳米结构具有显著的潜力.
更多相关视频
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
相关概念视频
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
